Insider Trading Alert - PTLA, TAL And EAT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 25, 2014, 97 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $508.38 to $15,061,515.27.

Highlighted Stocks Traded by Insiders:

Portola Pharmaceuticals (PTLA) - FREE Research Report

Dier Mardi, who is Executive VP and CFO at Portola Pharmaceuticals, sold 5,000 shares at $26.26 on Aug. 25, 2014. Following this transaction, the Executive VP and CFO owned 1,118 shares meaning that the stake was reduced by 81.73% with the 5,000-share transaction.

The shares most recently traded at $26.76, up $0.50, or 1.86% since the insider transaction. Historical insider transactions for Portola Pharmaceuticals go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 14,671
  • 24-Week # shares bought: 700,000
  • 24-Week # shares sold: 30,671

The average volume for Portola Pharmaceuticals has been 360,400 shares per day over the past 30 days. Portola Pharmaceuticals has a market cap of $1.0 billion and is part of the health care sector and drugs industry. Shares are up 4.23% year-to-date as of the close of trading on Monday.

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. Currently, there are 2 analysts who rate Portola Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PTLA - FREE

TheStreet Quant Ratings rates Portola Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Get the full Portola Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TAL International Group (TAL) - FREE Research Report

Dunner Adrian, who is Senior Vice President at TAL International Group, sold 8,000 shares at $45.10 on Aug. 25, 2014. Following this transaction, the Senior Vice President owned 81,976 shares meaning that the stake was reduced by 8.89% with the 8,000-share transaction.

The shares most recently traded at $45.62, up $0.52, or 1.15% since the insider transaction. Historical insider transactions for TAL International Group go as follows:

  • 4-Week # shares sold: 1,500
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 8,500

The average volume for TAL International Group has been 287,800 shares per day over the past 30 days. TAL International Group has a market cap of $1.5 billion and is part of the services sector and diversified services industry. Shares are down 19.91% year-to-date as of the close of trading on Monday.

TAL International Group, Inc., together with its subsidiaries, leases intermodal transportation equipment and provides maritime container management services worldwide. The company operates in two segments, Equipment Leasing and Equipment Trading. The stock currently has a dividend yield of 6.38%. The company has a P/E ratio of 12.0. Currently, there are 4 analysts who rate TAL International Group a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TAL - FREE

TheStreet Quant Ratings rates TAL International Group as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full TAL International Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Brinker International (EAT) - FREE Research Report

Thomson Roger F, who is EVP, Ch. Dev. Off. & Asst.Sec. at Brinker International, sold 27,000 shares at $49.38 on Aug. 25, 2014. Following this transaction, the EVP, Ch. Dev. Off. & Asst.Sec. owned 85,683 shares meaning that the stake was reduced by 23.96% with the 27,000-share transaction.

The shares most recently traded at $49.27, down $0.11, or 0.23% since the insider transaction. Historical insider transactions for Brinker International go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 5,993
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 5,993
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 5,993

The average volume for Brinker International has been 964,400 shares per day over the past 30 days. Brinker International has a market cap of $3.2 billion and is part of the services sector and leisure industry. Shares are up 6.95% year-to-date as of the close of trading on Monday.

Brinker International, Inc. owns, develops, operates, and franchises full-service casual dining restaurants under the Chili's Grill & Bar and Maggiano's Little Italy brands primarily in the United States. The stock currently has a dividend yield of 2.27%. The company has a P/E ratio of 21.9. Currently, there are 8 analysts who rate Brinker International a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EAT - FREE

TheStreet Quant Ratings rates Brinker International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Brinker International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round